Diabetes mellitus is a condition in which the pancreas no longer produces enough insulin or when cells stop responding to the insulin that is produced, so that glucose in the blood cannot be absorbed into the cells of the body. Symptoms include frequent urination, lethargy, excessive thirst, and hunger. The treatment includes changes in diet, oral medications, and in some cases, daily injections of insulin.
Insulin research points way to better diabetes (Type I diabetes) treatments – New research that significantly improves our understanding of how insulin interacts with cells in the human body is published today. The study could have major implications for the development of treatments for Type I diabetes.
Novo Nordisk receives US approval for Victoza? (liraglutide) for the treatment of type 2 diabetes – Novo Nordisk announced that the US Food and Drug Administration (FDA) has granted marketing authorisation for Victoza for the treatment of type 2 diabetes in adults.
UCLA study shows metformin is safe for patients with advanced heart failure and diabetes mellitus — Drug may improve survival rates for these patients – A new study has shown that metformin, a drug often used in the treatment of diabetes mellitus, is safe for use in treating patients who have both diabetes and advanced heart failure.
Childhood metabolic measurements may predict diabetes development years later – A child’s blood pressure, body mass index, blood glucose level and other laboratory tests and simple office measures may predict the risk of developing type 2 diabetes nine and 26 years later.
Pharmacists improve care of diabetics while cutting costs — UB program lowered A1C levels in diabetics and cut monthly costs by $212 per patient. – The role of pharmacists hasn’t received much attention in the debate on the cost of health care. But national and regional studies show that when pharmacists directly participate in patient care, they significantly reduce treatment costs and improve outcomes.
Drinking coffee, decaf and tea regularly associated with a reduced risk of diabetes – Drinking more coffee (regular or decaffeinated) or tea appears to lower the risk of developing type 2 diabetes, according to an analysis of previous studies reported in the December 14/28 issue of Archives of Internal Medicine, JAMA.
Study shows pine bark improves circulation, swelling and visual acuity in early diabetic retinopathy — Research reveals Pycnogenol is effective in visual improvement in subjects – Pycnogenol (pic-noj-en-all), an antioxidant plant extract from the bark of the French maritime pine tree, can improve microcirculation, retinal edema and visual acuity in the early stages of diabetic retinopathy.
Cardiovascular risk in youth with type 1 diabetes linked primarily to insulin resistance – Youth with type 1 diabetes have now been found to have abnormal insulin resistance. Having abnormal insulin resistance appears to negatively affect heart, blood vessel and exercise function in this population.
Sugary cola drinks linked for first time to higher risk of gestational diabetes – Researchers have found that drinking more than 5 servings of sugar sweetened cola a week prior to pregnancy appears to significantly elevate the risk of developing diabetes during pregnancy.
Diabetes cases to double and costs to triple by 2034 – In the next 25 years, spending on diabetes will almost triple, rising from $113 billion to $336 billion, even with no increase in the prevalence of obesity.
IDF releases important new guidelines to improve the treatment of diabetes worldwide — Guidelines address pregnancy, self-monitoring blood glucose and oral health. – The International Diabetes Federation (IDF) releases important new guidelines to improve the treatment of diabetes worldwide. The guidelines address pregnancy, self-monitoring blood glucose and oral health.
Diabetes weakens your bones – The inflammatory molecule TNF-a may contribute to delayed bone fracture healing in diabetics, revealed by researchers. Diabetes, a condition where the body either does not produce enough, or respond to, insulin, affects at least 171 million people worldwide, a figure that is likely to double by 2030.
